IMMUNOHISTOCHEMICAL LOCALIZATION OF INTRACELLULAR AND EXTRACELLULAR ASSOCIATED TGF-BETA IN THE SKIN OF PATIENTS WITH SYSTEMIC-SCLEROSIS (SCLERODERMA) AND PRIMARY RAYNAUD PHENOMENON

被引:54
|
作者
GABRIELLI, A
DILORETO, C
TABORRO, R
CANDELA, M
SAMBO, P
NITTI, C
DANIELI, MG
DELUSTRO, F
DASCH, JR
DANIELI, G
机构
[1] UNIV ANCONA, IST ANAT PATOL, I-60100 ANCONA, ITALY
[2] COLLAGEN CORP, PALO ALTO, CA 94303 USA
[3] CELTRIX LABS, PALO ALTO, CA 94303 USA
来源
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY | 1993年 / 68卷 / 03期
关键词
D O I
10.1006/clin.1993.1136
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have investigated the distribution of TGFβ using antibodies specific for its intracellular and extracellular forms in full-thickness biopsies of patients with SSc, primary Raynaud's phenomenon (PRP), systemic lupus erythematosus (SLE), and from normal subjects. Nine of 11 SSc biopsies demonstrated intracellular TGFβ in endothelial cells while only 6 exhibited extracellular TGFβ. Endothelial cells in skin biopsies of all PRP patients displayed both intracellular and extracellular TGFβ. All other control biopsies were negative. In patients with PRP, some positively staining fibroblasts were found scattered throughout the dermis. Lastly, extracellular TGFβ was localized in the papillary dermis of PRP and SSc biopsies and in all the dermal layers of SLE patients. No significant staining of TGFβ was observed in the endothelial cells, fibroblasts, or in the extracellular matrix of the majority of biopsies from normal subjects. These data suggest that TGFβ may be one of the cytokines involved in the early stages of pathogenesis of SSc, and that endothelial cells in SSc and PRP may be a source and/or a target of TGFβ. © 1993 Academic Press. All rights reserved.
引用
收藏
页码:340 / 349
页数:10
相关论文
共 50 条
  • [2] MORPHOLOGIC CHANGES IN THE DIGITAL ARTERIES OF PATIENTS WITH PROGRESSIVE SYSTEMIC-SCLEROSIS (SCLERODERMA) AND RAYNAUD PHENOMENON
    RODNAN, GP
    MYEROWITZ, RL
    JUSTH, GO
    MEDICINE, 1980, 59 (06) : 393 - 408
  • [3] INCREASED THROMBOXANE BIOSYNTHESIS IN PATIENTS WITH SYSTEMIC-SCLEROSIS AND RAYNAUD PHENOMENON
    REILLY, IAG
    ROY, L
    FITZGERALD, GA
    CLINICAL RESEARCH, 1986, 34 (01): : A191 - A191
  • [4] PROGRESSIVE SYSTEMIC-SCLEROSIS SINE SCLERODERMA IN A CHILD PRESENTING AS NOCTURNAL SEIZURES AND RAYNAUD PHENOMENON
    NAVON, P
    HALEVI, A
    BRAND, A
    BRANSKI, D
    RUBINOW, A
    ACTA PAEDIATRICA, 1993, 82 (01) : 122 - 123
  • [5] 3 SIBLINGS WITH SCLERODERMA (SYSTEMIC-SCLEROSIS) AND 2 WITH RAYNAUD PHENOMENON FROM A SINGLE KINDRED
    SHELDON, WB
    LURIE, DP
    MARICQ, HR
    KAHALEH, MB
    DELUSTRO, FA
    GIBOFSKY, A
    LEROY, EC
    ARTHRITIS AND RHEUMATISM, 1981, 24 (05): : 668 - 676
  • [6] 3 SIBLINGS WITH SCLERODERMA (SYSTEMIC-SCLEROSIS) AND 2 WITH RAYNAUD PHENOMENON FROM A SINGLE KINDRED
    SHELDON, WB
    MARICQ, HR
    KAHALEH, MB
    DELUSTRO, FA
    PEEPLES, CL
    TAN, EM
    LEROY, EC
    CLINICAL RESEARCH, 1980, 28 (01): : A150 - A150
  • [7] COMPARISON OF DIGITAL ARTERY PRESSURE RESPONSES TO LOCAL COOLING IN RAYNAUD PHENOMENON ASSOCIATED WITH SYSTEMIC LUPUS-ERYTHEMATOSUS, SYSTEMIC-SCLEROSIS AND PRIMARY RAYNAUD PHENOMENON
    ROSAL, EJ
    MARICQ, HR
    INTERNATIONAL JOURNAL OF MICROCIRCULATION-CLINICAL AND EXPERIMENTAL, 1988, 7 : S104 - S104
  • [8] PLASMA TGF-BETA IN SYSTEMIC-SCLEROSIS - A CROSS-SECTIONAL STUDY
    SNOWDEN, N
    COUPES, B
    HERRICK, A
    ILLINGWORTH, K
    JAYSON, MIV
    BRENCHLEY, PEC
    ANNALS OF THE RHEUMATIC DISEASES, 1994, 53 (11) : 763 - 767
  • [9] IMMUNOHISTOCHEMICAL DEMONSTRATION OF PROTEOGLYCANS IN THE SKIN OF PATIENTS WITH SYSTEMIC-SCLEROSIS
    KITABATAKE, M
    ISHIKAWA, H
    MAEDA, H
    BRITISH JOURNAL OF DERMATOLOGY, 1983, 108 (03) : 257 - 262
  • [10] The role of TGF-beta isoforms in the microvasculature of systemic sclerosis skin
    Helman, S
    Cotton, SA
    Jayson, MIV
    Hoyland, J
    Herrick, A
    Freemont, AJ
    JOURNAL OF PATHOLOGY, 1997, 181 : A32 - A32